Clinical Trials for RhuMAb 2C4 (Pertuzumab)

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticVICCBRE1157
05/01/2012
A Randomized Multicenter, Double-blind, Placebo-Controlled Comparison of Chemotherapy plus Trastuzumab plus Placebo versus Chemotherapy plus Trastuzumab plus Pertuzumab as Adjuvant Therapy in Patients with operable HER2-Positive Primary Breast Cancer

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.